Skip to main content

Tenon Medical Inc

For the period ended Jun 30, 2024. Filed Aug 13, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 13, 2024

TNON$1.74-0.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Operations and Comprehensive Loss

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

(In thousands, except per share data)

Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
Revenue$901$743$1,620$1,176
Cost of sales4315496801,029
Gross Profit470194940147
Operating Expenses
Research and development7089011,3771,735
Sales and marketing1,4481,8832,8293,909
General and administrative2,1861,7324,1123,711
Total Operating Expenses4,3424,5168,3189,355
Loss from Operations(3,872)(4,322)(7,378)(9,208)
Other Income (Expense)
Gain on investments39376693
Interest expense——(34)—
Other income (expense), net7—(56)—
Total Other Income (Expense), net4637(24)93
Net Loss$(3,826)$(4,285)$(7,402)$(9,115)
Net Loss Per Share of Common Stock
Basic and diluted$(1.02)$(3.28)$(2.24)$(7.50)
Weighted-Average Shares of Common Stock Outstanding
Basic and diluted3,7491,3053,3011,215
Consolidated Statements of Comprehensive Loss:
Net loss$(3,826)$(4,285)$(7,402)$(9,115)
Unrealized gain on investments—3—16
Foreign currency translation adjustment—134612
Total comprehensive loss$(3,826)$(4,269)$(7,356)$(9,087)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.